{
    "code": "02021383",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021383",
    "time": "2017-05-05 03:36:38",
    "許可證字號": "衛署藥輸字第021383號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/09\/30",
    "發證日期": "87\/12\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202138300",
    "中文品名": "輸活能液態吸入劑",
    "英文品名": "SUPRANE (DESFLURANE)",
    "適應症": "吸入性全身麻醉劑。\r\n說明：\r\n麻醉誘導\r\nSUPRANE適用於成人在住院及門診手術誘導期之吸入性麻醉劑。\r\nSUPRANE禁用做為兒科病患誘導用之吸入性麻醉劑，因為它會導致中至重度的上呼吸道不良反應。\r\n麻醉維持\r\nSUPRANE適用於成人與兒科病患住院或門診手術之吸入性麻醉維持。\r\n若以本藥以外之吸入性麻醉藥來誘導與氣管插管，SUPRANE可用在小孩及嬰兒麻醉維持。\r\nSUPRANE不適用於非插管之幼童麻醉維持，因為SUPRANE極可能造成幼童之呼吸不良反應，包括：咳嗽、咽喉痙攣或刺激分泌產生。",
    "劑型": "479吸入用液劑",
    "包裝": "240毫升玻璃瓶裝 240毫升鋁瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DESFLURANE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1316201100  瑞帝股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F370018000  Baxter Healthcare Corporation",
        "製造廠廠址": "Route 3, Km 144.2, Guayama, Puerto Rico 00784",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049010009 麻醉劑Anesthetics",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2804001800",
            "成分名稱": "DESFLURANE",
            "含量描述": "NLT 99.0",
            "含量": "",
            "單位": "%"
        }
    ],
    "仿單外盒": [
        {
            "title": "02 021383仿單-106-03-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021383&Seq=005&Type=9"
        },
        {
            "title": "Labeling 02021383-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021383&Seq=004&Type=8"
        }
    ]
}